Award
NIH Reporter #1R21NS144529-01A1
Defining the potential of GSK3 inhibition in correcting the molecular phenotypes of CTNNB1 syndrome patient derived glutamatergic neurons.
Recipient
TUFTS UNIVERSITY BOSTON
Award Amount
$453,750.00
Ceiling
$453,750.00
Awarded
August 26, 2026
Identifier
1R21NS144529-01A1
NIH grant awarded to study GSK3 inhibition as a therapeutic strategy for CTNNB1 syndrome using patient-derived neurons.
Description
This is a NIH grant award notice for a project focused on the molecular and functional phenotypes of CTNNB1 syndrome and testing the efficacy of GSK3 inhibitors in patient-derived neurons. The project aims to develop therapeutic strategies for this neurodevelopmental disorder.